Retagliptin (SP2086) is a selective, competitive and orally active dipeptidyl peptidase-4 (DPP-4) inhibitor. Retagliptin can be used for type 2 diabetes mellitus (T2DM) research[1].
Molecular Weight:
464.36
Purity:
99.70
CAS Number:
[1174122-54-3]
Formula:
C19H18F6N4O3
Target:
Dipeptidyl Peptidase
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted